Collegium Pharmaceutical, Inc (COLL) — 10-Q Filings
All 10-Q filings from Collegium Pharmaceutical, Inc. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
- 10-Q Filing — May 7, 2026
-
Collegium Pharma's Q3 Net Income Soars 237% on Strong Revenue Growth
— Nov 6, 2025 Risk: medium
Collegium Pharmaceutical, Inc. reported a significant increase in product revenues, reaching $209.361 million for the three months ended September 30, 2025, up -
Collegium Accelerates Share Buybacks, Boosts Equity Plan
— Aug 7, 2025 Risk: low
COLLEGIUM PHARMACEUTICAL, INC reported a significant share repurchase activity, with the company repurchasing $10.0 million of its common stock during the three -
Collegium Pharmaceutical Files Q1 2025 10-Q
— May 8, 2025 Risk: medium
Collegium Pharmaceutical, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the fir -
Collegium Pharma Details Q3 Share Repurchases
— Nov 7, 2024 Risk: medium
Collegium Pharmaceutical, Inc. reported its third-quarter results for the period ending September 30, 2024. The company's filing details various share repurchas -
Collegium Pharma Buys Back Stock, Repurchases $48M in May
— Aug 8, 2024 Risk: medium
Collgium Pharmaceutical, Inc. reported its Q2 2024 results, highlighting an accelerated share repurchase program initiated in May 2024, under which $48 million -
Collegium Pharmaceutical, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
COLLEGIUM PHARMACEUTICAL, INC (COLL) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Collegium Pharmaceutical, Inc. filed a 10-Q report for the per
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX